Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children

[1] Peterson CG(2002)A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease Am J Gastroenterol 97 1755-1762

[2] Eklund E(1998)Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 182-205

[3] Taha Y(2007)Laboratory values for children with newly diagnosed inflammatory bowel disease Pediatrics 119 1113-1119

[4] Raab Y(2002)Fecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children Acta Paediatr 91 45-50

[5] Carlson M(2019)Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-a protocol for systematic review and meta-analysis Medicine 98 14834-217

[6] Fiocchi C(2015)Neutrophil-to-lymphocyte ratio in inflammatory bowel disease–as a new predictor of disease severity Bratisl Lek Listy 116 213-497

[7] Mack DR(2012)Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity Clin Res Hepatol Gastroenterol 36 491-432

[8] Langton C(2007)Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study Gastroenterology 133 423-447

[9] Markowitz J(1991)Development and validation of a pediatric Crohn’s disease activity index J Pediatr Gastroenterol Nutr 12 439-1517

[10] LeLeiko N(2004)Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences Gastroenterology 126 1504-3212

[1] Peterson CG(2002)A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease Am J Gastroenterol 97 1755-1762

[2] Eklund E(1998)Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 115 182-205

[3] Taha Y(2007)Laboratory values for children with newly diagnosed inflammatory bowel disease Pediatrics 119 1113-1119

[4] Raab Y(2002)Fecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children Acta Paediatr 91 45-50

[5] Carlson M(2019)Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-a protocol for systematic review and meta-analysis Medicine 98 14834-217

[6] Fiocchi C(2015)Neutrophil-to-lymphocyte ratio in inflammatory bowel disease–as a new predictor of disease severity Bratisl Lek Listy 116 213-497

[7] Mack DR(2012)Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity Clin Res Hepatol Gastroenterol 36 491-432

[8] Langton C(2007)Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study Gastroenterology 133 423-447

[9] Markowitz J(1991)Development and validation of a pediatric Crohn’s disease activity index J Pediatr Gastroenterol Nutr 12 439-1517

[10] LeLeiko N(2004)Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences Gastroenterology 126 1504-3212